Clinical Trials

Showing trials with last updates posted in 2025.

NCT05870748 | TERMINATED | PHASE2/PHASE3
600 participants

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2023-07-12
Completion:
2025-08-26
Conditions
  • Ovarian Cancer
  • Epithelial Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Cancer
  • Platinum-resistant Ovarian Cancer
Interventions
  • DRUG
No Results Yet
NCT05735730 | ACTIVE_NOT_RECRUITING | NA
1800 participants

Can the Risk for AMD be Modulated?

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2023-06-26
Completion:
2025-02-06
Conditions
  • Age-Related Macular Degeneration (ARMD)
Interventions
  • OTHER
No Results Yet
NCT05645575 | RECRUITING | NA
30 participants

In-patient SCC TMS

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2025-04-01
Completion:
2027-02-22
Conditions
  • Major Depressive Disorder
Interventions
  • DEVICE
No Results Yet
NCT05371548 | RECRUITING | NA
3250 participants

Smart About Meds (SAM) RCT

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2023-02-01
Completion:
2027-06-30
Conditions
  • Medication Adherence
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page